Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-052402
Filing Date
2024-12-30
Accepted
2024-12-30 08:30:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 229089
2 form424b3_001.jpg GRAPHIC 2843
  Complete submission text file 0001493152-24-052402.txt   234236
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283993 | Film No.: 241587000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)